Related Experiment Video
Updated: May 30, 2026
07:20
Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Spotlight on denosumab in postmenopausal osteoporosis
1Adis, a Wolters Kluwer Business, Auckland, New Zealand. demail@adis.co.nz
Summary
Denosumab effectively treats postmenopausal osteoporosis by reducing fracture risk and increasing bone mineral density (BMD). This monoclonal antibody offers a convenient subcutaneous injection for improved treatment adherence in women at high risk of fractures.
Area of Science:
- Endocrinology
- Bone Biology
- Pharmacology
Background:
- Postmenopausal osteoporosis poses a significant fracture risk.
- Current treatments have limitations in efficacy and adherence.
- Denosumab offers a novel mechanism targeting bone resorption.
Purpose of the Study:
- To evaluate denosumab's efficacy and safety in treating postmenopausal osteoporosis.
- To compare denosumab with placebo and alendronate in different patient populations.
- To assess denosumab's impact on bone mineral density (BMD) and bone turnover markers.
Main Methods:
- Phase III FREEDOM study (placebo-controlled, 3 years).
- DECIDE and STAND studies (1-year, comparing denosumab and alendronate).
- Assessment of fracture incidence, BMD, and bone turnover markers.
Main Results:
- Denosumab significantly reduced vertebral, nonvertebral, and hip fractures versus placebo.
- Denosumab increased BMD and decreased bone turnover markers more than alendronate.
- Generally well-tolerated, with long-term effects of low bone turnover pending.
Conclusions:
- Denosumab is a valuable treatment for postmenopausal osteoporosis, reducing fracture risk.
- Its efficacy in increasing BMD and favorable administration may improve adherence.
- Considered a potential first-line option, especially for patients intolerant to other therapies.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:31Essential Minerals for Bone Health
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.